My Cart

0 Item(s): $0.00

You have no items in your shopping cart.

Pct With Nolvadex

pct with nolvadex

Nolvadex PCT

Tamoxifen Citrate, most common known as Nolvadex is one of the most popular SERM’s any performance enhancer will ever use and as such Nolvadex PCT use remains the most common purpose. Post Cycle Therapy (PCT) is a very important part of the anabolic steroid plan as this is the period after use is discontinued that allows the body to normalize; an important factor in maintaining good health as well as protecting gains made while on cycle. A plan based on a Nolvadex PCT can readily and efficiently produce the desired end very thoroughly and make ones experience not only more enjoyable but more effective as well.

The use of Nolvadex in Post Cycle Therapy (PCT)

Another major use of Nolvadex among athletes and bodybuilders is its effectiveness in stimulating the production of Testosterone as shown by many studies. This is achieved through its actions on the hypothalamus and pituitary glands of the brain as well as stimulating the production of Follicle Stimulating Hormone as well as Luteinizing Hormone. These in turn activate the production of Testosterone in the testes. Nolvadex is therefore used during PCT which comes immediately after completion of the anabolic steroid cycle as well as clearance of all anabolic steroids from a person’s system. When used in Post Cycle Therapy (PCT).

History

Nolvadex was first developed in 1992 by ICI and later launched in the United States. Interestingly, Nolvadex was first used as a medicine in a treatment for female infertility. After several clinical studies however, it was discovered that Nolvadex is very effective in breast cancer treatment. It was finally approved as a breast cancer treatment in by the FDA in 1977. In 1988, it was further approved as a preventive measure for people at high risk of contractingfbreast cancer.

Nolvadex For Gynecomastia

As mentioned earlier, Nolvadex is widely used in the performance enhancement and bodybuilding world as an ancillary help to reducing, combating and preventing Gynecomastia development. This is especially possible when a moderate anabolic steroid is used in a cycle. Nolvadex is used in doses of around 10 – 30mg a day. The common dose used by many people is 20mg Nper day. Using high dosages of Nolvadex beyond 20 – 40mg a day does not lead to any significant effect in reducing gynecomastia.

Tamoxifen drug recommended dosing

Four weeks is typical term for PCT. Duration of Tamox Citrate use is driven by capability of the roid stack.

Reducing Tamox speed to almost 10 milligram every day needed during the 2nd half of your therapy. Tamoxifene amount on 1st two weeks - near twenty mg ED.

 Buterol is certainly full-package. For highest muscular mass maintenance include near fifty micrograms of Clenbuterol with Tamox PCT. Tamox plan is 2 take back bodybuilders testosterone hormone on-board.

Super-Sized Nolvadex PCT Plan

While this will not be necessary for many PCT plans for quite a few it can be highly advised. Cycles that extend into the 12 week duration and beyond are often benefited by the following plan, especially those that include very suppressive anabolic steroids. For this super-sized version we are simply adding Human Chorionic Gonadotropin (hCG) into the equation thereby promoting a more efficient recovery. With this plan the same Nolvadex PCT plan listed above will be used, the only change will be the introduction of hCG ten days prior to Nolvadex therapy. A steady daily dose of hCG at 1,000iu per day is often a very effective dosing when applied every day for ten days before the Nolvadex PCT portion of the plan is implemented.

Storage

Store Nolvadex between 68 and 77 degrees F (20 and 25 degrees C) in a tightly closed, light-resistant container. Store away from moisture, heat, and light. Do not store in the bathroom. Do not take tablets after the expiration date printed on the label. Keep Nolvadex out of the reach of children and away from pets.

Know More About This Medicine and Buy Now : MedyPharma.com

Loading...